Diversified Chemicals

Hunstman

Two Plants Close in Rotterdam Chemical Cluster Amid High Energy Costs

RBC Capital Analyst Maintains Hold Rating on Huntsman with a Price Target of $15.00

Huntsman released FY2026 Q1 earnings on April 30 After-Market EST, actual revenue USD 1.42 B (forecast USD 1.39 B), actual EPS USD -0.3063 (forecast USD -0.235)

Huntsman Reports Q1 Net Loss of $35 Million

Huntsman to Release FY2026 Q1 Earnings on April 30 After-Market EST, Forecast Revenue USD 1.39 B, EPS USD -0.235

Arun Viswanathan Maintains Hold Rating on Huntsman with a Target Price of $14.00

BASF and others raise MDI product prices

Huntsman Announces Fourth Quarter 2025 Earnings

Huntsman released FY2025 annual earnings on February 17 After-Market EST, actual revenue USD 5.683 B (forecast USD 5.664 B), actual EPS USD -1.6521 (forecast USD -1)

Huntsman released FY2025 Q4 earnings on February 17 After-Market (EST), actual revenue USD 1.355 B (forecast USD 1.343 B), actual EPS USD -0.5556 (forecast USD -0.305)

Huntsman to release FY2025 Q4 earnings on February 17 After-Market EST, forecast revenue USD 1.343 B, EPS USD -0.305

UBS Analyst Maintains Hold Rating for Huntsman with a Target Price of $12.00

Dow Europe Raises MDI Prices by 300 Euros per Ton

American Century Companies Increased Shares of Huntsman

Huntsman revises Q4 2025 EBITDA outlook downward due to Rotterdam plant shutdown

JPMorgan Downgrades Huntsman's Target Price

Huntsman Reports Quarterly Loss and Revenue Decline

Huntsman released FY2025 9 Months Earnings on November 6 After-Market EST, with actual revenue of USD 4.328 B and EPS of USD -1.0901

Huntsman released FY2025 Q3 earnings on November 6 After-Market EST, actual revenue USD 1.46 B (forecast USD 1.444 B), actual EPS USD -0.1457 (forecast USD -0.14)

Huntsman to Release FY2025 Q3 Earnings on November 6 After-Market EST, Forecast Revenue USD 1.442 B, EPS USD -0.14

OPTIMI HEALTH CORP

HCW Biologics

Silexion Therapeutics

Vida Global

GCL Global

BiomX

MetaVia

Micware

MicroAlgo

Ordinary dividend (cash)

Ex Date: 2026.06.15 (EST), Cash dividend 0.0875 USD

RBC Capital analyst Arun Viswanathan has maintained a Hold rating on Huntsman (HUN) with a price target of $15.00. Viswanathan, a 4-star analyst, has an average return of 4.2% and a 53.49% success rate. Citi's Patrick Cunningham also issued a Hold rating for Huntsman, while Bank of America Securities reiterated a Sell rating on the stock.

Tip Ranks

ROYAL BANK OF CANADA

Albemarle

Sherwin Williams

Citigroup

Bank of America

CITIGROUP INC 6.250 NON CUM SER II PFD WI

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

RBC Capital Sticks to Its Hold Rating for Huntsman (HUN)

Huntsman Corporation held its 2026 Annual Meeting of Shareholders, where shareholders rejected a proposal for an independent board chair. The meeting included votes on director elections and executive compensation, with over 87% of shares represented. CEO Peter Huntsman emphasized the board's recommendation against the independent chair proposal, citing the need for continuity. Additionally, CFO Phil Lister addressed a recent Moody's downgrade, stating it was anticipated due to industry conditions, and reassured shareholders about the company's financial management.

Market Beat

Moodys

DuPont de Nemours

DUPONT DE NEMOURS INC

Huntsman Annual Meeting: Shareholders Reject Independent Chair Proposal as Moody’s Downgrade Looms

Huntsman (NYSE:HUN) reported quarterly earnings of ($0.20) per share, beating estimates of ($0.21) by $0.01. The company had revenue of $1.42 billion, exceeding expectations of $1.39 billion, with a year-over-year revenue increase of 0.7%. Despite a negative net margin of 5.00% and a negative return on equity of 3.97%, Huntsman announced a quarterly dividend of $0.0875 per share, payable on June 30. Analysts have mixed sentiments, with some indicating signs of demand stability while others express concerns over ongoing profitability pressures.

JPMorgan Chase

UBS Group AG

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Huntsman (NYSE:HUN) Releases Earnings Results, Beats Estimates By $0.01 EPS

Huntsman (HUN) reported Q1 2026 results with sales of $1,420 million and a net loss of $53 million, a decline from a $5 million loss last year. Despite an 8.45% one-day share price increase and a 41.02% year-to-date rise, the stock is considered 13.2% overvalued at $14.37 against a fair value of $12.69. The company faces risks from European cost pressures and weak construction demand, but potential pricing power from eco-friendly solutions may support long-term growth. Investors are advised to consider both risks and opportunities in their analysis.

Simplywall

Assessing Huntsman (HUN) Valuation After Wider Q1 2026 Loss And Modest Sales Uptick

Huntsman shares are trading higher after the company reported better-than-expected Q1 sales results.

benzinga_article

Huntsman Corporation reported a widened net loss of $53 million for Q1, compared to a loss of $5 million last year, with a loss per share of $0.31. Revenues slightly increased to $1,420 million from $1,410 million. After hours, HUN shares traded at $15.00, up 4.38%.

nasdaq

Nasdaq

Huntsman Corporation Q1 Loss Widens

Alembic Global analyst Hassan Ahmed has maintained a Buy rating on Huntsman (HUN) with a price target of $14.00. Ahmed, a 4-star analyst, has an average return of 7.1% and a 48.70% success rate. The current analyst consensus on Huntsman is a Hold, with an average price target of $12.20.

Methanex

Alembic Global Keeps Their Buy Rating on Huntsman (HUN)

Hunstman(HUN.US)